A phase II study of OPN-300 in patients with autism

Trial Profile

A phase II study of OPN-300 in patients with autism

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Oct 2015

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Autistic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Oct 2015 Status changed from planning to recruiting, as per Optinose media release.
    • 21 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top